Data Foundry

Drug recalls 2026

Formoterol Fumarate Inhalation Solution — Class II drug recall D-0073-2027

Ongoing recall by The Ritedose Corporation, reported 2026-11-04, distributed nationwide. Failed Impurities/Degradation Specification

Recall numberD-0073-2027
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmThe Ritedose Corporation, Columbia, SC, United States
Recall initiated2026-10-15
Classified2026-10-23
Reported by FDA2026-11-04
DistributedNationwide (US)
Quantity3,210 cartons
Reason classesspecification failure
NDC76204-0030, 76204-0030-01, 76204-0030-02
Lot numbers25BL0
Expiration dates2027-02-28

Product

Formoterol Fumarate Inhalation Solution, 20mcg/2mL, packaged in cartons of 30 individually wrapped vials (NDC 76204-030-01) and 60 individually wrapped vials (NDC 76204-030-02), Rx only, Manufactured for and by: Ritedose Pharmaceuticals, LLC, Columbia, SC

Reason for recall

Failed Impurities/Degradation Specification

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0073-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-11-10. Not affiliated with or endorsed by FDA. Not medical or legal advice.